デフォルト表紙
市場調査レポート
商品コード
1713593

植込み型インスリンポンプの世界市場レポート 2025年

Implantable Insulin Pump Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
植込み型インスリンポンプの世界市場レポート 2025年
出版日: 2025年04月23日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

植込み型インスリンポンプ市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.5%で55億7,000万米ドルに成長します。予測期間の成長は、糖尿病患者人口の拡大、個別化医療の採用の増加、糖尿病管理の効率化への注目の高まり、非侵襲的モニタリングソリューションの需要拡大、ヘルスケアインフラとアクセス性の拡大に起因しています。予測期間における主な動向としては、より良いインスリン管理のためのAIと機械学習の統合、デバイスの小型化の強化、モバイルアプリやクラウドベースのシステムとの統合、安全機構を強化したポンプの開発、継続的な研究開発とイノベーションなどが挙げられます。

糖尿病の有病率の増加は、植込み型インスリンポンプ市場の拡大を促進すると予想されます。糖尿病は、インスリンの生産が不十分であったり、細胞によるインスリンの使用が効果的でなかったりするために、体内で血糖値の管理が困難になることを特徴とする慢性疾患です。糖尿病患者の増加は、肥満率の上昇、座りがちなライフスタイル、食生活の乱れ、高齢化などの要因によるものです。植え込み型インスリンポンプは、正確で持続的なインスリン投与を可能にし、血糖値を安定させ、頻繁な注射の必要性を減らし、全体的な糖尿病管理と生活の質を向上させる。例えば、2024年5月に英国糖尿病協会(Diabetes UK)が発表した報告書によると、英国の糖尿病患者数は560万人を超え、前年から16万7,822人増加しました。その結果、糖尿病罹患率の急増が植込み型インスリンポンプ市場の成長を促進しています。

植込み型インスリンポンプ市場の主要企業は、リアルタイムのグルコースデータに基づく自動インスリン投与により患者の予後を改善するクローズドループインスリンポンプシステムなどの先進製品の開発に注力しています。人工膵臓として知られるクローズドループインスリンポンプシステムは、リアルタイムのグルコース情報を利用して、手動介入なしにインスリン注入を調整します。例えば、インドの医療機器会社であるメドトロニック・インディア社は、2022年3月にミニメド780Gシステムを発表しました。この次世代型クローズドループインスリンポンプシステムは、基礎インスリンと補正用ボーラスを5分ごとに投与し、血糖値の安定を助ける。100mg/dLという低いグルコース目標値をカスタマイズできるのが特徴で、他の先進ハイブリッドシステムと比較して優れたグルコースコントロールを提供します。このシステムのBluetooth接続により、ユーザーとケアパートナーは、互換性のあるiOSおよびAndroidアプリを通じてリアルタイムのグルコースデータと動向を監視することができ、最適なパフォーマンスを得るために必要な最小限の調整で管理を簡素化することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界植込み型インスリンポンプ PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の植込み型インスリンポンプ市場:成長率分析
  • 世界の植込み型インスリンポンプ市場の実績:規模と成長, 2019-2024
  • 世界の植込み型インスリンポンプ市場の予測:規模と成長, 2024-2029, 2034F
  • 世界植込み型インスリンポンプ総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の植込み型インスリンポンプ市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 閉ループインスリンポンプ
  • オープンループインスリンポンプ
  • 世界の植込み型インスリンポンプ市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 1型糖尿病
  • 2型糖尿病
  • 世界の植込み型インスリンポンプ市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • ホームケア
  • 世界の植込み型インスリンポンプ市場閉ループインスリンポンプのサブセグメンテーション(タイプ別)、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 完全自動化閉ループインスリンポンプ
  • ハイブリッド閉ループインスリンポンプ
  • 持続血糖モニタリング(CGM)機能付き閉ループインスリンポンプ
  • 適応型インスリン供給機能を備えた閉ループインスリンポンプ
  • 世界の植込み型インスリンポンプ市場オープンループインスリンポンプの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 手動オープンループインスリンポンプ
  • ファンデーション・ボーラスオープンループインスリンポンプ
  • スマートオープンループインスリンポンプ
  • パッチ型オープンループインスリンポンプ

第7章 地域別・国別分析

  • 世界の植込み型インスリンポンプ市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の植込み型インスリンポンプ市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 植込み型インスリンポンプ市場:競合情勢
  • 植込み型インスリンポンプ市場:企業プロファイル
    • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Dexcom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Tandem Diabetes Care Inc.
  • Ypsomed Holding AG
  • Air Liquide Healthcare Ltd.
  • Diabeloop SA
  • Glooko Inc.
  • ViCentra B.V.
  • Bigfoot Biomedical Inc.
  • Beta Bionics Inc.
  • Senseonics Holdings Inc.
  • INREDA DIABETIC B.V.
  • TIDEPOOL Inc.
  • Medtrum Technologies Inc.
  • Sernova Corp.
  • PhysioLogic Devices Inc.
  • EOFLOW CO. LTD.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 植込み型インスリンポンプ市場2029:新たな機会を提供する国
  • 植込み型インスリンポンプ市場2029:新たな機会を提供するセグメント
  • 植込み型インスリンポンプ市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33495

An implantable insulin pump is a surgically implanted device designed to deliver insulin directly into the peritoneal cavity, continuously adjusting doses based on the patient's needs. This device helps individuals with diabetes maintain stable blood sugar levels, reducing the risk of long-term complications and providing a more effective alternative to daily insulin injections.

The main types of implantable insulin pumps are closed-loop insulin pumps and open-loop insulin pumps. Closed-loop insulin pumps, also known as artificial pancreas systems, are advanced devices that automatically regulate blood sugar levels. They are used for managing both type 1 and type 2 diabetes and are utilized in various settings, including hospitals and home care environments.

The implantable insulin pumps market research report is one of a series of new reports from The Business Research Company that provides implantable insulin pumps market statistics, including implantable insulin pumps industry global market size, regional shares, competitors with a implantable insulin pumps market share, detailed implantable insulin pumps market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable insulin pumps industry. This implantable insulin pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable insulin pump market size has grown strongly in recent years. It will grow from $3.54 billion in 2024 to $3.88 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the increasing prevalence of diabetes, improvements in insulin delivery systems, growing awareness of diabetes management, rising patient demand for convenience, and supportive government regulations for diabetes care.

The implantable insulin pump market size is expected to see strong growth in the next few years. It will grow to $5.57 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to expanding patient population with diabetes, rising adoption of personalized medicine, increasing focus on diabetes management efficiency, growing demand for non-invasive monitoring solutions, and expanding healthcare infrastructure and accessibility. Major trends in the forecast period include the integration of AI and machine learning for better insulin management, enhancements in device miniaturization, integration with mobile apps and cloud-based systems, the development of pumps with enhanced safety mechanisms, and ongoing research and innovations.

The growing prevalence of diabetes is anticipated to drive the expansion of the implantable insulin pump market. Diabetes is a chronic condition characterized by the body's difficulty in managing blood sugar levels due to insufficient insulin production or ineffective use of insulin by cells. The increase in diabetes cases is attributed to factors such as rising obesity rates, sedentary lifestyles, poor diets, and an aging population. Implantable insulin pumps provide precise, continuous insulin delivery, which helps stabilize blood glucose levels, reduces the need for frequent injections, and enhances overall diabetes management and quality of life. For example, a report from Diabetes UK in May 2024 highlighted that there were over 5.6 million people with diabetes in the UK, reflecting an increase of 167,822 cases from the previous year. Consequently, the surge in diabetes incidence is propelling the growth of the implantable insulin pump market.

Key players in the implantable insulin pump market are focusing on developing advanced products, such as closed-loop insulin pump systems, to enhance patient outcomes through automated insulin delivery based on real-time glucose data. Known as an artificial pancreas, a closed-loop insulin pump system uses real-time glucose information to adjust insulin infusion without manual intervention. For instance, Medtronic India Pvt. Ltd., an India-based medical device company, introduced the MiniMed 780G system in March 2022. This next-generation closed-loop insulin pump system delivers basal insulin and correction boluses every five minutes to help stabilize blood sugar levels. It features customizable glucose targets as low as 100 mg/dL, offering superior glucose control compared to other advanced hybrid systems. The system's Bluetooth connectivity allows users and their care partners to monitor real-time glucose data and trends through compatible iOS and Android apps, simplifying management with minimal adjustments required for optimal performance.

In June 2024, Arecor Therapeutics plc, a UK-based biotechnology firm, partnered with Medtronic plc to develop a high-concentration, thermostable insulin for use in Medtronic's advanced implantable insulin pumps. This collaboration aims to improve treatment for diabetes patients who require intensive insulin management. Medtronic plc, based in Ireland, is a manufacturer of implantable insulin pumps.

Major companies operating in the implantable insulin pump market are Sanofi S.A., Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD., CamDiab Ltd.

North America was the largest region in the implantable insulin pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable insulin pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable insulin pump market consists of sales of pump devices, delivery catheters, control systems, and insulin reservoirs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Insulin Pump Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable insulin pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable insulin pump market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Closed-Loop Insulin Pump; Open-Loop Insulin Pump
  • 2) By Application: Type 1 Diabetes; Type 2 Diabetes
  • 3) By End-User: Hospitals; Home-Care
  • Subsegments:
  • 1) By Closed-Loop Insulin Pump: Fully Automated Closed-Loop Insulin Pump; Hybrid Closed-Loop Insulin Pump; Closed-Loop Insulin Pump with Continuous Glucose Monitoring (CGM); Closed-Loop Insulin Pump with Adaptive Insulin Delivery
  • 2) By Open-Loop Insulin Pump: Manual Open-Loop Insulin Pump; Basal-Bolus Open-Loop Insulin Pump; Smart Open-Loop Insulin Pump; Patch-Style Open-Loop Insulin Pump
  • Companies Mentioned: Sanofi S.A.; Abbott Laboratories; Medtronic plc; Dexcom Inc.; Insulet Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Insulin Pump Market Characteristics

3. Implantable Insulin Pump Market Trends And Strategies

4. Implantable Insulin Pump Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Insulin Pump Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Insulin Pump PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Insulin Pump Market Growth Rate Analysis
  • 5.4. Global Implantable Insulin Pump Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Insulin Pump Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Insulin Pump Total Addressable Market (TAM)

6. Implantable Insulin Pump Market Segmentation

  • 6.1. Global Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Closed-Loop Insulin Pump
  • Open-Loop Insulin Pump
  • 6.2. Global Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 1 Diabetes
  • Type 2 Diabetes
  • 6.3. Global Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Home-Care
  • 6.4. Global Implantable Insulin Pump Market, Sub-Segmentation Of Closed-Loop Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fully Automated Closed-Loop Insulin Pump
  • Hybrid Closed-Loop Insulin Pump
  • Closed-Loop Insulin Pump with Continuous Glucose Monitoring (CGM)
  • Closed-Loop Insulin Pump with Adaptive Insulin Delivery
  • 6.5. Global Implantable Insulin Pump Market, Sub-Segmentation Of Open-Loop Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Open-Loop Insulin Pump
  • Basal-Bolus Open-Loop Insulin Pump
  • Smart Open-Loop Insulin Pump
  • Patch-Style Open-Loop Insulin Pump

7. Implantable Insulin Pump Market Regional And Country Analysis

  • 7.1. Global Implantable Insulin Pump Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Insulin Pump Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Insulin Pump Market

  • 8.1. Asia-Pacific Implantable Insulin Pump Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Insulin Pump Market

  • 9.1. China Implantable Insulin Pump Market Overview
  • 9.2. China Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Insulin Pump Market

  • 10.1. India Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Insulin Pump Market

  • 11.1. Japan Implantable Insulin Pump Market Overview
  • 11.2. Japan Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Insulin Pump Market

  • 12.1. Australia Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Insulin Pump Market

  • 13.1. Indonesia Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Insulin Pump Market

  • 14.1. South Korea Implantable Insulin Pump Market Overview
  • 14.2. South Korea Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Insulin Pump Market

  • 15.1. Western Europe Implantable Insulin Pump Market Overview
  • 15.2. Western Europe Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Insulin Pump Market

  • 16.1. UK Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Insulin Pump Market

  • 17.1. Germany Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Insulin Pump Market

  • 18.1. France Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Insulin Pump Market

  • 19.1. Italy Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Insulin Pump Market

  • 20.1. Spain Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Insulin Pump Market

  • 21.1. Eastern Europe Implantable Insulin Pump Market Overview
  • 21.2. Eastern Europe Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Insulin Pump Market

  • 22.1. Russia Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Insulin Pump Market

  • 23.1. North America Implantable Insulin Pump Market Overview
  • 23.2. North America Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Insulin Pump Market

  • 24.1. USA Implantable Insulin Pump Market Overview
  • 24.2. USA Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Insulin Pump Market

  • 25.1. Canada Implantable Insulin Pump Market Overview
  • 25.2. Canada Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Insulin Pump Market

  • 26.1. South America Implantable Insulin Pump Market Overview
  • 26.2. South America Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Insulin Pump Market

  • 27.1. Brazil Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Insulin Pump Market

  • 28.1. Middle East Implantable Insulin Pump Market Overview
  • 28.2. Middle East Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Insulin Pump Market

  • 29.1. Africa Implantable Insulin Pump Market Overview
  • 29.2. Africa Implantable Insulin Pump Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Insulin Pump Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Insulin Pump Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Insulin Pump Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Insulin Pump Market Competitive Landscape
  • 30.2. Implantable Insulin Pump Market Company Profiles
    • 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dexcom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Insulin Pump Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care Inc.
  • 31.2. Ypsomed Holding AG
  • 31.3. Air Liquide Healthcare Ltd.
  • 31.4. Diabeloop SA
  • 31.5. Glooko Inc.
  • 31.6. ViCentra B.V.
  • 31.7. Bigfoot Biomedical Inc.
  • 31.8. Beta Bionics Inc.
  • 31.9. Senseonics Holdings Inc.
  • 31.10. INREDA DIABETIC B.V.
  • 31.11. TIDEPOOL Inc.
  • 31.12. Medtrum Technologies Inc.
  • 31.13. Sernova Corp.
  • 31.14. PhysioLogic Devices Inc.
  • 31.15. EOFLOW CO. LTD.

32. Global Implantable Insulin Pump Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Insulin Pump Market

34. Recent Developments In The Implantable Insulin Pump Market

35. Implantable Insulin Pump Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Insulin Pump Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Insulin Pump Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Insulin Pump Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33495_Implantable_Insulin_Pump_GMR_2025